STIM2 and breast carcinoma: This can be achieved by future studies utilizing techniques including siRNA to perform a specific knockdown of STIM1 and STIM2, which will enable researchers to identify the specific roles of these proteins in the TLR4-induced signaling of breast cancer cells.